GERN

bullish SHIFT track record →

Geron grants stock options under Nasdaq rules

Watch: Monitor IMpactMF Phase 3 trial readout timing for RYTELO, which could reshape revenue guidance and investor sentiment.

Full analysis

Geron approved a stock option grant under Nasdaq Listing Rule 5635(c)(4) through its 2018 Inducement Award Plan, announced April 14, 2026. This follows recent insider buying totaling over $220K across four insiders at prices near $1.18 to $1.76. Institutional ownership remains concentrated with Citadel holding over 10.7M shares, reflecting ongoing investor interest despite a 21.5% price pullback from the 52-week high.

New stock incentives alongside insider buying indicate potential management confidence in executing growth amid accelerating revenue momentum and commercial progress with RYTELO.

Compare

vs NVDA vs AMD vs AAPL vs TSLA vs MSFT vs META vs GOOGL vs AMZN vs TSM vs ASML

Evidence

15h ago Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) benzinga

1d ago Insider buy by LAWLIS VIRGIL BRYAN JR. (GERN): $15,667

1d ago Insider buy by SAMUELS SCOTT ALAN (GERN): $24,150

1d ago Insider buy by ZIEGLER JAMES (GERN): $160,000

1d ago Insider buy by SCARLETT JOHN A (GERN): $22,062

32d ago Geron Corporation (GERN) Reports Q4 EPS of (5c) yahoo-finance

41d ago Geron (GERN) Sets 2026 Financial Goals, TD Cowen Cuts PT yahoo-finance

48d ago GERON ($GERN) Releases Q4 2025 Earnings - Quiver Quantitative google-news-insider

8 signals · latest 15h ago

Get alerted when GERN changes direction

We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.

All stocks → Our calls → How it works →